Disciplined Equity Management’s Gilead Sciences GILD Stock Holding History

Disciplined Equity Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200	Closed	-$16.2K	–	82
2023 Q4	$16.2K	Hold	200	–	–	0.01%	85
2023 Q3	$15K	Hold	200	–	–	0.01%	49
2023 Q2	$15.4K	Hold	200	–	–	0.01%	49
2023 Q1	$16.6K	Sell	200 -27,386	-99%	-$2.27M	0.01%	49
2022 Q4	$2.37M	Sell	27,586 -40	-0.1%	-$3.17K	2.09%	6
2022 Q3	$1.7M	Sell	27,626 -50	-0.2%	-$3.15K	1.68%	7
2022 Q2	$1.71M	Buy	27,676 +546	+2%	+$33.8K	1.55%	11
2022 Q1	$1.61M	Buy	+27,130	New	+$1.73M	1.62%	13

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Disciplined Equity Management's GILD Position: Q1 2024 in Review

Disciplined Equity Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 200 shares — an estimated $16.2K sold.

Disciplined Equity Management first reported a position in GILD in Q1 2022 and held it in 8 quarters. The position peaked at $2.37M in Q4 2022. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

Disciplined Equity Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
Disciplined Equity Management sold 200 Gilead Sciences shares in Q1 2024, an estimated $16.2K.
Disciplined Equity Management first reported a position in Gilead Sciences in Q1 2022 and held it in 8 quarters.
Disciplined Equity Management's Gilead Sciences position peaked at $2.37M in Q4 2022.
1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Disciplined Equity Management's 13F filing for Q1 2024, filed 3 May 2024.